Arkolith/Insider Trading/PDSB/Form 4

Bedu-Addo Frank

President/CEO, DirectorPDS Biotechnology Corp (PDSB) · full profile →Form 4 · filed Jul 25, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 12, 2025Grant(A)150K—$0150K
Feb 28, 2024Grant(A)300K—$0300K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-027405) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML